Neurological Biomarkers Are Estimated To Witness High Growth Market Dynamics:
The growing prevalence of neurological disorders has been a key driver for the neurological biomarkers market. According to World Health Organization estimates, over 1 billion people globally suffer from neurological disorders with Alzheimer's disease and other dementias affecting over 55 million people worldwide. Such high disease prevalence has created significant need for...
0 Acciones
1029 Views
0 Vista previa